Further studies are required to better understand the mechanisms underlying perineural invasion and NT-3 involvement, as well as the effects of XRT and CIRT, in this metastatic pathway, as well as to improve clinical treatment protocols for patients with such aggressive tumours. The gene discussed is NTF3; the disease is neoplasm.